New Mouse Model for Nemaline Myopathy
Author Information
Author(s): Coulson Zachary, Kolb Justin, Sabha Nesrin, Karimi Esmat, Hourani Zaynab, Ottenheijm Coen, Granzier Henk, Dowling James J.
Primary Institution: Hospital for Sick Children
Hypothesis
Changing the intronic sequence that produces the novel pseudoexon would result in production of a stable transcript and thus more closely model the impact of the human NEB exon 55 deletion.
Conclusion
The new Hmz-NebΔExon55 mouse model closely recapitulates the human disease phenotype of nemaline myopathy, providing a valuable tool for future research and therapy development.
Supporting Evidence
- The new model has a significant reduction in pseudoexon formation (93.6% reduction).
- Hmz-NebΔExon55 mice have a median survival of 136 days, significantly longer than previous models.
- Motor impairments were observed in Hmz-NebΔExon55 mice as early as 30 days of age.
- Hmz-NebΔExon55 mice exhibit characteristic features of nemaline myopathy at physiological, histological, and molecular levels.
Takeaway
Scientists created a new mouse model to study a muscle disease called nemaline myopathy, which helps them understand the disease better and find new treatments.
Methodology
The Hmz-NebΔExon55 mouse was generated using CRISPR-Cas9 to delete a portion of intronic sequence and replace it with a human intron sequence.
Limitations
The model may not fully replicate all aspects of human disease due to species differences.
Statistical Information
P-Value
0.0173
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website